Ads
related to: anticancer agents- Recommended Dosing
Determine The Appropriate Dosing
For A Patient On IMFINZI.
- Clinical Study Results
View Clinical Study Results
& Efficacy Info For IMFINZI.
- Request Representative
Fill Out A Brief Form To Request
Assistance From A Representative.
- Safety Information
Learn About Safety & Efficacy
Information For IMFINZI.
- Recommended Dosing
Search results
Results From The WOW.Com Content Network
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
1.09 Alkylating agents: Altretamine: PO Alkylates DNA. Recurrent or advanced ovarian cancer Myelosuppression, peripheral neuropathy, seizures and hepatotoxicity (rare). Bendamustine: IV: Alkylates DNA. Chronic lymphocytic leukaemia, mantle cell lymphoma and non-Hodgkin's lymphoma. Myelosuppression, hypokalaemia and tachycardia. Busulfan: IV, PO ...
Chemotherapy (often abbreviated chemo, sometimes CTX and CTx) is the type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents or alkylating agents) in a standard regimen.
Extracts from Camptotheca (the "happy tree" or "cancer tree") were used to develop the chemotherapeutic drug Topotecan. Plant sources of anti-cancer agents are plants, the derivatives of which have been shown to be usable for the treatment or prevention of cancer in humans.
As a result, the entire antibody, linker and cytotoxic (anti-cancer) agent enter the targeted cancer cell where the antibody is degraded into an amino acid. The resulting complex – amino acid, linker and cytotoxic agent – is considered to be the active drug. In contrast, cleavable linkers are detached by enzymes in the cancer cell. The ...
diagnostic agent Lendalizumab [41] mab: humanized: C5: Lenvervimab [5] mab: humanized: hepatitis B surfage antigen: hepatitis B Lenzilumab [6] mab: human: CSF2: chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia: Lerdelimumab [17] mab: human: TGF-β2: reduction of scarring after glaucoma surgery: Leronlimab [5] mab: humanized ...